Back to Search
JOHN BARTLETT, PHARMD
PHARMD
Pharmacist
NPI: 1902057102Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
61501(CA)
Research & Publications (20)
Assessing the contribution of fibrinogen in predicting risk of death in men with peripheral arterial disease.
PMID 19036067·J Thromb Haemost·2009
8-other
External quality assurance of HER2 FISH and ISH testing: three years of the UK national external quality assurance scheme.
PMID 19095573·Am J Clin Pathol·2009
4-observational
Determination of HER2 amplification by in situ hybridization: when should chromosome 17 also be determined?
PMID 19019769·Am J Clin Pathol·2008
8-other
Type 1 receptor tyrosine kinase profiles identify patients with enhanced benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial.
PMID 18768436·J Clin Oncol·2008
2-rct
Reliability, repeatability and reproducibility: analysis of measurement errors in continuous variables.
PMID 18306169·Ultrasound Obstet Gynecol·2008
4-observational
External quality assurance of HER2 fluorescence in situ hybridisation testing: results of a UK NEQAS pilot scheme.
PMID 16963466·J Clin Pathol·2007
4-observational
Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy.
PMID 17906205·J Clin Oncol·2007
8-other
Identifying indigenous peoples for health research in a global context: a review of perspectives and challenges.
PMID 18018843·Int J Circumpolar Health·2007
6-review
Generic and branded drugs for the treatment of people living with HIV/AIDS.
PMID 17329500·J Int Assoc Physicians AIDS Care (Chic)·2007
6-review
Framework for Aboriginal-guided decolonizing research involving Métis and First Nations persons with diabetes.
PMID 17689163·Soc Sci Med·2007
8-other
Mechanosensitive channel gating transitions resolved by functional changes upon pore modification.
PMID 16935962·Biophys J·2006
8-other
Long-term results of initial therapy with abacavir and Lamivudine combined with Efavirenz, Amprenavir/Ritonavir, or Stavudine.
PMID 16967040·J Acquir Immune Defic Syndr·2006
4-observational
Minimizing resistance consequences after virologic failure on initial combination therapy: a systematic overview.
PMID 16540933·J Acquir Immune Defic Syndr·2006
6-review
Detection of HER2 gene amplification by fluorescence in situ hybridization in breast cancer.
PMID 16491609·Methods Mol Med·2006
8-other
An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults.
PMID 17053351·AIDS·2006
6-review
Type I receptor tyrosine kinases are associated with hormone escape in prostate cancer.
PMID 15685688·J Pathol·2005
8-other
Psychophysics of electrical stimulation of striate cortex in macaques.
PMID 16079195·J Neurophysiol·2005
7-preclinical
Pharmacodiagnostic testing in breast cancer: focus on HER2 and trastuzumab therapy.
PMID 16196500·Am J Pharmacogenomics·2005
6-review
Conceptions and dimensions of health and well-being for Métis women in Manitoba.
PMID 15736632·Int J Circumpolar Health·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 QUALITY DR
VACAVILLE, CA 95688 - Phone
- (707) 453-5000
Quick Facts
- NPI
- 1902057102
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile